A detailed history of Whitener Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Whitener Capital Management, Inc. holds 26,120 shares of ABT stock, worth $3.03 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
26,120
Previous 26,616 1.86%
Holding current value
$3.03 Million
Previous $2.77 Million 7.67%
% of portfolio
0.85%
Previous 0.84%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$100.07 - $118.13 $49,634 - $58,592
-496 Reduced 1.86%
26,120 $2.98 Million
Q2 2024

Jul 17, 2024

BUY
$100.73 - $112.44 $204,985 - $228,815
2,035 Added 8.28%
26,616 $2.77 Million
Q1 2024

Apr 16, 2024

SELL
$109.52 - $120.96 $17,961 - $19,837
-164 Reduced 0.66%
24,581 $2.79 Million
Q4 2023

Jan 10, 2024

SELL
$90.19 - $110.4 $3,337 - $4,084
-37 Reduced 0.15%
24,745 $2.72 Million
Q3 2023

Nov 02, 2023

BUY
$95.53 - $114.62 $9,553 - $11,462
100 Added 0.41%
24,782 $2.4 Million
Q2 2023

Jul 13, 2023

BUY
$100.78 - $112.29 $67,522 - $75,234
670 Added 2.79%
24,682 $2.69 Million
Q4 2022

Mar 01, 2023

SELL
$95.06 - $111.52 $28,518 - $33,456
-300 Reduced 1.23%
24,012 $2.64 Million
Q3 2022

Oct 28, 2022

BUY
$96.76 - $112.03 $19,352 - $22,406
200 Added 0.83%
24,312 $2.35 Million
Q2 2022

Aug 09, 2022

BUY
$102.07 - $123.37 $6,838 - $8,265
67 Added 0.28%
24,112 $2.62 Million
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $25,654 - $31,284
225 Added 0.94%
24,045 $2.85 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $2.57 Million - $3.15 Million
22,270 Added 1436.77%
23,820 $3.35 Million
Q4 2021

Feb 07, 2022

SELL
$115.53 - $141.46 $2.27 Million - $2.78 Million
-19,622 Reduced 92.68%
1,550 $218,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $182,339 - $201,720
-1,563 Reduced 6.87%
21,172 $2.32 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $185,132 - $217,927
1,750 Added 8.34%
22,735 $2.64 Million
Q1 2021

May 11, 2021

SELL
$108.84 - $128.23 $20,353 - $23,979
-187 Reduced 0.88%
20,985 $2.51 Million
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $67,200 - $73,228
-640 Reduced 2.93%
21,172 $2.32 Million
Q3 2020

Oct 09, 2020

BUY
$91.64 - $111.29 $123,714 - $150,241
1,350 Added 6.6%
21,812 $2.37 Million
Q2 2020

Jul 17, 2020

BUY
$76.57 - $98.0 $94,410 - $120,834
1,233 Added 6.41%
20,462 $1.87 Million
Q1 2020

Apr 24, 2020

BUY
$62.82 - $91.86 $116,217 - $169,941
1,850 Added 10.65%
19,229 $1.52 Million
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $209,621 - $233,358
2,670 Added 18.15%
17,379 $1.51 Million
Q2 2019

Aug 02, 2019

BUY
$72.88 - $85.0 $36,440 - $42,500
500 Added 3.52%
14,709 $1.24 Million
Q1 2019

May 02, 2019

BUY
$66.22 - $80.06 $6,622 - $8,006
100 Added 0.71%
14,209 $1.14 Million
Q4 2018

Feb 06, 2019

BUY
$65.56 - $74.27 $4,851 - $5,495
74 Added 0.53%
14,109 $1.02 Million
Q3 2018

Nov 07, 2018

BUY
$60.81 - $73.36 $27,364 - $33,012
450 Added 3.31%
14,035 $1.03 Million
Q2 2018

Aug 08, 2018

BUY
$57.57 - $63.54 $5,757 - $6,354
100 Added 0.74%
13,585 $828,000
Q1 2018

Apr 23, 2018

BUY
$56.27 - $63.62 $112,540 - $127,240
2,000 Added 17.41%
13,485 $808,000
Q4 2017

Apr 23, 2018

BUY
$53.68 - $57.47 $616,514 - $660,042
11,485
11,485 $655,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Whitener Capital Management, Inc. Portfolio

Follow Whitener Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Whitener Capital Management, Inc. with notifications on news.